Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,300 JPY | +3.94% | +6.68% | +28.94% |
May. 13 | Jefferies Adjusts CKD'S Price Target to 3,700 Yen From 4,000 Yen, Keeps at Buy | MT |
Apr. 15 | AstraZeneca: expects a sharp rise in kidney disease | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.94% | 1.37B | |
+3.94% | 15.7B | |
+35.87% | 5.37B | |
-2.22% | 5.11B | |
-3.68% | 4.81B | |
-18.09% | 4.51B | |
+14.13% | 4.38B | |
+17.86% | 4.02B | |
+45.38% | 3.98B | |
+0.19% | 3.3B |
- Stock Market
- Equities
- 6407 Stock
- News CKD Corporation
- Algernon Pharmaceuticals Receives Notice of Allowance From Japanese Patent Office for Repirinast and Treatment of CKD